Manere, the 21 cent raise was not to fund additional trials. The cap raise was sold on the premise that the company needed some extra cash to tide it over until the CE Mark was granted in March. No way was it for additional trials.
Research, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
